Monitor for any future conversion of the pre-funded warrant into common shares, which would increase the effective stake. As a passive filing, no near-term activist pressure is expected, but the sizable position signals conviction in Sagimet's pipeline.
Price Chart
Executive Summary
Commodore Capital LP filed a Schedule 13G disclosing a 7.6% passive beneficial ownership stake in Sagimet Biosciences as of September 30, 2026. The stake consists of 5,507,752 shares (including pre-funded warrants) and is held through Commodore Capital Master LP. This is a new passive filing by this filer, indicating a meaningful but non-activist position in the clinical-stage biotech.
Key Financial Metrics
Key Facts
- Commodore Capital LP disclosed a 7.6% beneficial ownership stake in Sagimet Biosciences as of September 30, 2026.
- The stake comprises 5,507,752 shares, including 2,757,742 common shares and 2,750,010 shares issuable upon exercise of a pre-funded warrant.
- The filing is passive under Rule 13d-1(c) with no intent to influence control.
- Ownership percentage is based on 69,965,450 shares outstanding plus 2,750,010 pre-funded warrant shares.
- The pre-funded warrant is subject to a 9.99% beneficial ownership limitation.
Financial Impact
7.6% passive stake valued at approximately $5.5 million based on share count and typical pre-funded warrant pricing; no direct financial impact on the company.
Risk Factors
- Pre-funded warrant exercise could lead to modest dilution if the beneficial ownership limitation is waived or adjusted.
- Commodore Capital could convert to an activist 13D filing if circumstances change, though no such intent is indicated.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001831942-26-000045 |
| Document: 0001831942-26-000045-index-headers.html | 0001831942-26-000045 |
| Document: 0001831942-26-000045-index.html | 0001831942-26-000045 |
| Document: 0001831942-26-000045.txt | 0001831942-26-000045 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $9.95 $9.58 | ▼ −3.72% | ▼ −3.20% | $9.56 (−3.97%) |
Oct 7, 2026 19d ago | SC 13G | $8.92 $8.93 | ▲ +0.11% | ▼ −0.49% | $9.56 (+7.12%) |
Oct 1, 2026 25d ago | Press Release | $9.14 $9.03 | ▲ +1.20% | ▲ +1.88% | $9.56 (−4.54%) |
Sep 30, 2026 27d ago | Press Release | $9.88 $9.37 | ▲ +5.16% | ▲ +5.34% | $9.56 (+3.29%) |
Sep 30, 2026 27d ago | 8-K | $9.88 $9.37 | ▼ −5.16% | ▼ −5.34% | $9.56 (−3.29%) |
Sep 22, 2026 4w ago | Institutional Cluster | $11.09 $10.42 | ▼ −6.04% | ▼ −5.32% | $9.56 (−13.84%) |
Aug 25, 2026 9w ago | Press Release | $10.29 $10.86 | ▲ +5.54% | ▲ +5.52% | $9.56 (−7.14%) |
Aug 11, 2026 11w ago | 8-K | $9.52 $9.39 | ▼ −1.37% | ▼ −1.62% | $9.56 (+0.37%) |
Aug 11, 2026 11w ago | Press Release | $9.52 $9.39 | ▼ −1.37% | ▼ −1.62% | $9.56 (+0.37%) |
Jul 22, 2026 13w ago | Insider Cluster | $7.01 $7.07 | ▲ +0.86% | ▲ +0.75% | $9.56 (+36.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers